Biotech

Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: ...

Sarepta Therapeutics and University of Western Australia Announce Exclusive Worldwide Licensing Agreement for Exon-Skipping Program in Duchenne Muscular Dystrophy

CAMBRIDGE, MA and PERTH, AUSTRALIA: Deal Enables Development of New Exon-Skipping Drug Candidates in DMD ...

Theratechnologies Announces Financial Results for First Quarter of 2013

MONTREAL, CANADA: ...

Mincom Capital Inc. and Group Nanoxplore Inc. Sign Letter of Intent for a Qualifying Transaction

OTTAWA, ONTARIO: ...

Data Presented at AACR Annual Meeting Support Targeted Immune Reactivation Mechanism and Potential of Peregrine's Bavituximab in Solid Tumor Therapy

TUSTIN, CA: Imaging Studies Show Docetaxel Strongly Upregulates Bavituximab's PS Target in Tumors, Further Supporting Lead Clinical Indication in Second Line Non-Small Cell Lung Cancer; Preclinical Studies S ...

Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options

TORONTO, ONTARIO: ...

TissueGen Announces ELUTE(TM) Biodegradable Drug-Loaded Fiber

DALLAS, TX: Enables Fibers Loaded With Widest Selection of Drugs and Therapeutic Agents Possible for Use in Implantable Medical Devices ...

Jennerex Announces Presentation of Data Demonstrating Pexa-Vec's Vascular Targeting Mechanism

SAN FRANCISCO, CA: Pre-Clinical Data Presented by Donald McDonald Laboratory, University of California San Francisco, at the American Association for Cancer Research Meeting 2013 ...

Helix BioPharma Corp. Announces L-DOS47 Scientific Poster to Be Presented at American Association for Cancer Research Annual Meeting in Washington, DC

AURORA, ON: ...

Theratechnologies Announces Termination of Agreement With Ferrer

MONTREAL, QUEBEC: ...